I disagree. I think the PR is properly worded to set the expectations of a trial continuation. Those who believe different are generally the eternal.optimists on this board. When NP uses words like "hopefully" and "potential" that means set your expectations low. He hopefully wanted to release the DSMC recommendation last week but I'm guessing the trial stoppage didn't happen so a PR and a webcast ensue to let us know the various options going forward. It will be disappointing if a trial size increase is recommended, I think an endpoint change or a continuation are positive. My view, but based on market reaction to the PR, I think most expect a continuation of some kind.